[HTML][HTML] Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston …

J Nixon, C McHugh, S Jones - Clinical medicine, 2013 - ncbi.nlm.nih.gov
Neuromuscular disease is one of the most common indications for the use of intravenous
immuno-globulin (IVIG). We describe practical aspects of IVIG administration and dosing in …

Intravenous immune globulin usage for neurological and neuromuscular disorders: an academic centre, 4 years experience

L Sarti, T Falai, F Pinto, E Tendi, S Matą - Neurological sciences, 2009 - Springer
Intravenous immune globulin (IVIg) use for labeled and unlabeled indications has grown in
the last years. Aim of this study was to evaluate the IVIg usage profile for neurological …

The use of IVIg in the treatment of inflammatory polyneuropathies and myasthenia gravis at The Walton Centre

S Kimyongur, B Hywel, J Holt - Journal of the Royal College …, 2019 - journals.sagepub.com
Background Immunoglobulin is a blood product used in a variety of medical disorders,
usually delivered intravenously (IVIg). Neurology patients, particularly those with …

A retrospective analysis of the safety profile of intravenous immunoglobulin in 1176 patients receiving home infusion therapy

N Souayah, A Pahwa, L Burawski, T Opila… - Journal of clinical …, 2018 - journals.lww.com
Objectives: This analysis assessed the safety of intravenous immunoglobulin (IVIg) in the
treatment of patients with neuroimmunological and immunological disorders in a home …

Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions

M Rigas, R Tandan, RJ Sterling - Journal of Clinical …, 2008 - journals.lww.com
Objective: To examine the overall safety of intravenous immunoglobulin (IVIG) administered
according to a clinically defined, home-based therapeutic regimen in patients with …

Intravenous immunoglobulin in autoimmune neuromuscular diseases

MC Dalakas - Jama, 2004 - jamanetwork.com
ContextIntravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating
expression and function of Fc receptors, interfering with activation of complement and …

[HTML][HTML] Off-label use of intravenous immunoglobulin for neurological conditions: a review of clinical effectiveness

D Sutton, S Visintini - 2018 - europepmc.org
The purpose of this Rapid Response Report is to collect, critically appraise and evaluate the
current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin …

Practical aspects of transitioning from intravenous to subcutaneous immunoglobulin therapy in neuromuscular disorders

D Menon, E Sarpong, V Bril - Canadian Journal of Neurological …, 2022 - cambridge.org
Recent evidence shows that subcutaneous immunoglobulin (SCIG) is as efficacious as
intravenous immunoglobulin (IVIG) and has a better safety profile and acceptance rate …

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

MC Dalakas - Pharmacology & therapeutics, 2004 - Elsevier
Intravenous immunoglobulin (IVIg) has multiple actions on the immunoregulatory network
that operate in concert with each other. For each autoimmune neuromuscular disease …

Home IVIG for CIDP: a focus on patient centred care

HD Katzberg, V Rasutis, V Bril - Canadian Journal of Neurological …, 2013 - cambridge.org
Objective: To determine the safety and tolerability of home-based intravenous
immunoglobulin (IVIG)(Gamunex) as maintenance treatment in patients with chronic …